US Stock MarketDetailed Quotes

ALXO ALX Oncology

Watchlist
  • 0.973
  • +0.080+8.93%
Close Mar 11 16:00 ET
  • 1.020
  • +0.047+4.79%
Post 16:13 ET
51.96MMarket Cap-0.38P/E (TTM)

ALX Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-16.33%142.47M
-36.25%30.61M
-38.87%32.57M
12.91%41.53M
17.26%37.76M
33.62%170.28M
49.05%48.02M
45.24%53.28M
8.84%36.78M
30.13%32.2M
Selling and administrative expenses
-8.39%26.09M
13.50%7.08M
-18.82%6.1M
-5.80%6.87M
-18.75%6.05M
-1.90%28.48M
-11.15%6.24M
2.88%7.51M
3.61%7.3M
-3.05%7.44M
-General and administrative expense
-8.39%26.09M
13.50%7.08M
-18.82%6.1M
-5.80%6.87M
-18.75%6.05M
-1.90%28.48M
-11.15%6.24M
2.88%7.51M
3.61%7.3M
-3.05%7.44M
Research and development costs
-17.93%116.37M
-43.68%23.53M
-42.16%26.47M
17.54%34.65M
28.08%31.72M
44.10%141.8M
65.83%41.78M
55.76%45.77M
10.22%29.48M
45.04%24.76M
Operating profit
16.33%-142.47M
36.25%-30.61M
38.87%-32.57M
-12.91%-41.53M
-17.26%-37.76M
-33.62%-170.28M
-49.05%-48.02M
-45.24%-53.28M
-8.84%-36.78M
-30.13%-32.2M
Net non-operating interest income expense
-15.93%7.64M
-43.76%1.45M
-18.77%1.86M
-6.97%2.13M
14.09%2.2M
124.85%9.08M
63.71%2.58M
67.11%2.29M
162.47%2.29M
766.67%1.92M
Non-operating interest income
-12.05%9.37M
-37.30%1.88M
-13.97%2.3M
-3.86%2.56M
13.46%2.62M
148.92%10.65M
65.74%3M
95.40%2.68M
204.34%2.67M
927.11%2.31M
Non-operating interest expense
10.48%1.73M
2.89%427K
14.07%446K
15.32%429K
10.34%427K
557.56%1.57M
79.65%415K
19,450.00%391K
18,500.00%372K
12,800.00%387K
Other net income (expense)
-105.14%-20K
96.55%-1K
400.00%3K
-102.47%-8K
-114.74%-14K
1,868.18%389K
-1,350.00%-29K
85.71%-1K
6,580.00%324K
1,287.50%95K
Other non- operating income (expenses)
-105.14%-20K
96.55%-1K
400.00%3K
-102.47%-8K
-114.74%-14K
1,868.18%389K
-1,350.00%-29K
85.71%-1K
6,580.00%324K
1,287.50%95K
Income before tax
16.14%-134.85M
35.87%-29.16M
39.78%-30.71M
-15.34%-39.4M
-17.88%-35.58M
-30.29%-160.81M
-48.38%-45.47M
-44.37%-50.99M
-3.76%-34.16M
-23.03%-30.18M
Income tax
0
0
Net income
16.14%-134.85M
35.87%-29.16M
39.78%-30.71M
-15.34%-39.4M
-17.88%-35.58M
-30.23%-160.81M
-48.07%-45.47M
-44.37%-50.99M
-3.76%-34.16M
-23.03%-30.18M
Net income continuous Operations
16.14%-134.85M
35.87%-29.16M
39.78%-30.71M
-15.34%-39.4M
-17.88%-35.58M
-30.23%-160.81M
-48.07%-45.47M
-44.37%-50.99M
-3.76%-34.16M
-23.03%-30.18M
Minority interest income
Net income attributable to the parent company
16.14%-134.85M
35.87%-29.16M
39.78%-30.71M
-15.34%-39.4M
-17.88%-35.58M
-30.23%-160.81M
-48.07%-45.47M
-44.37%-50.99M
-3.76%-34.16M
-23.03%-30.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
16.14%-134.85M
35.87%-29.16M
39.78%-30.71M
-15.34%-39.4M
-17.88%-35.58M
-30.23%-160.81M
-48.07%-45.47M
-44.37%-50.99M
-3.76%-34.16M
-23.03%-30.18M
Basic earnings per share
31.02%-2.58
40.22%-0.55
53.23%-0.58
9.52%-0.76
4.05%-0.71
-23.43%-3.74
-22.67%-0.92
-42.53%-1.24
-3.70%-0.84
-23.33%-0.74
Diluted earnings per share
31.02%-2.58
40.22%-0.55
53.23%-0.58
9.52%-0.76
4.05%-0.71
-23.43%-3.74
-22.67%-0.92
-42.53%-1.24
-3.70%-0.84
-23.33%-0.74
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -16.33%142.47M-36.25%30.61M-38.87%32.57M12.91%41.53M17.26%37.76M33.62%170.28M49.05%48.02M45.24%53.28M8.84%36.78M30.13%32.2M
Selling and administrative expenses -8.39%26.09M13.50%7.08M-18.82%6.1M-5.80%6.87M-18.75%6.05M-1.90%28.48M-11.15%6.24M2.88%7.51M3.61%7.3M-3.05%7.44M
-General and administrative expense -8.39%26.09M13.50%7.08M-18.82%6.1M-5.80%6.87M-18.75%6.05M-1.90%28.48M-11.15%6.24M2.88%7.51M3.61%7.3M-3.05%7.44M
Research and development costs -17.93%116.37M-43.68%23.53M-42.16%26.47M17.54%34.65M28.08%31.72M44.10%141.8M65.83%41.78M55.76%45.77M10.22%29.48M45.04%24.76M
Operating profit 16.33%-142.47M36.25%-30.61M38.87%-32.57M-12.91%-41.53M-17.26%-37.76M-33.62%-170.28M-49.05%-48.02M-45.24%-53.28M-8.84%-36.78M-30.13%-32.2M
Net non-operating interest income expense -15.93%7.64M-43.76%1.45M-18.77%1.86M-6.97%2.13M14.09%2.2M124.85%9.08M63.71%2.58M67.11%2.29M162.47%2.29M766.67%1.92M
Non-operating interest income -12.05%9.37M-37.30%1.88M-13.97%2.3M-3.86%2.56M13.46%2.62M148.92%10.65M65.74%3M95.40%2.68M204.34%2.67M927.11%2.31M
Non-operating interest expense 10.48%1.73M2.89%427K14.07%446K15.32%429K10.34%427K557.56%1.57M79.65%415K19,450.00%391K18,500.00%372K12,800.00%387K
Other net income (expense) -105.14%-20K96.55%-1K400.00%3K-102.47%-8K-114.74%-14K1,868.18%389K-1,350.00%-29K85.71%-1K6,580.00%324K1,287.50%95K
Other non- operating income (expenses) -105.14%-20K96.55%-1K400.00%3K-102.47%-8K-114.74%-14K1,868.18%389K-1,350.00%-29K85.71%-1K6,580.00%324K1,287.50%95K
Income before tax 16.14%-134.85M35.87%-29.16M39.78%-30.71M-15.34%-39.4M-17.88%-35.58M-30.29%-160.81M-48.38%-45.47M-44.37%-50.99M-3.76%-34.16M-23.03%-30.18M
Income tax 00
Net income 16.14%-134.85M35.87%-29.16M39.78%-30.71M-15.34%-39.4M-17.88%-35.58M-30.23%-160.81M-48.07%-45.47M-44.37%-50.99M-3.76%-34.16M-23.03%-30.18M
Net income continuous Operations 16.14%-134.85M35.87%-29.16M39.78%-30.71M-15.34%-39.4M-17.88%-35.58M-30.23%-160.81M-48.07%-45.47M-44.37%-50.99M-3.76%-34.16M-23.03%-30.18M
Minority interest income
Net income attributable to the parent company 16.14%-134.85M35.87%-29.16M39.78%-30.71M-15.34%-39.4M-17.88%-35.58M-30.23%-160.81M-48.07%-45.47M-44.37%-50.99M-3.76%-34.16M-23.03%-30.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 16.14%-134.85M35.87%-29.16M39.78%-30.71M-15.34%-39.4M-17.88%-35.58M-30.23%-160.81M-48.07%-45.47M-44.37%-50.99M-3.76%-34.16M-23.03%-30.18M
Basic earnings per share 31.02%-2.5840.22%-0.5553.23%-0.589.52%-0.764.05%-0.71-23.43%-3.74-22.67%-0.92-42.53%-1.24-3.70%-0.84-23.33%-0.74
Diluted earnings per share 31.02%-2.5840.22%-0.5553.23%-0.589.52%-0.764.05%-0.71-23.43%-3.74-22.67%-0.92-42.53%-1.24-3.70%-0.84-23.33%-0.74
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Alibaba
BABA
+4.89%
Tesla
TSLA
+3.79%
Netflix
NFLX
+3.28%
Broadcom
AVGO
+3.06%
NVIDIA
NVDA
+1.66%

Unlock the Full List